Clinical Trial: Efficacy and Safety of Kabalin Cap.(Pregabalin) in Patients With Neuropathic Pain

U.S., Nov. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07930260) titled 'Efficacy and Safety of Kabalin Cap.(Pregabalin) in Patients With Neuropathic Pain' on Nov. 05.

Brief Summary: This study aims to assess the proportion of patients with peripheral or central neuropathic pain who achieve at least a 50% improvement in pain at Week 12 after receiving Kabalin Cap.(Pregabalin). The study will also evaluate changes in pain characteristics, severity, and intensity; improvement in pain-related sleep interference; and safety information collected during the study period.

Study Start Date: Feb. 27, 2025

Study Type: OBSERVATIONAL

Condition: Peripheral or Central Neuropathic Pain

Recruitment Status: RECRUIT...